pharmanews

💊 MALE BIRTH CONTROL: THE NEW FRONTIER

$BTC
The pharmaceutical landscape is shifting! A new non-hormonal male birth control pill, NLS-133, has successfully moved into Phase II clinical trials. Early results show it can effectively stop sperm production without long-term side effects. If approved, this would be the first major innovation in male contraception in decades. Watch this space for "Big Pharma" moves!
$BNB
Follow Me for revolutionary science updates!
$RLS
Reference 1: FirstWord Pharma (April 2026)

Reference 2: NEXT Life Sciences (April 2026)

#MedicalBreakthrough #PharmaNews #Innovation

Innovent x Eli Lilly Strike $8.85B Deal 💊🔥
Innovent Biologics and Eli Lilly announced a new strategic collaboration in oncology & immunology — their 7th partnership in over a decade.
💰 Deal Highlights:
🔹 $350M upfront payment
🔹 Up to $8.5B in milestone payments
🔹 Tiered royalties on global sales (ex-Greater China)
Another massive cross-border biotech deal signaling strong confidence in next-gen therapies.
#Biotech #Healthcare #EliLilly #Innovent #PharmaNews